Cargando…
Predicting response of immunotherapy and targeted therapy and prognosis characteristics for renal clear cell carcinoma based on m1A methylation regulators
In recent years, RNA methylation modification has been found to be related to a variety of tumor mechanisms, such as rectal cancer. Clear cell renal cell carcinoma (ccRCC) is most common in renal cell carcinoma. In this study, we get the RNA profiles of ccRCC patients from ArrayExpress and TCGA data...
Autores principales: | Li, Lei, Tan, Hongwei, Zhou, Jiexue, Hu, Fengming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403615/ https://www.ncbi.nlm.nih.gov/pubmed/37542141 http://dx.doi.org/10.1038/s41598-023-39935-4 |
Ejemplares similares
-
Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma
por: Zhang, Li, et al.
Publicado: (2022) -
m(6)A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021) -
Prognosis-related genes participate in immunotherapy of renal clear cell carcinoma possibly by targeting dendritic cells
por: Fang, Guodong, et al.
Publicado: (2022) -
EMILIN2 is associated with prognosis and immunotherapy in clear cell renal cell carcinoma
por: Zhao, Guangjian, et al.
Publicado: (2022) -
TLR4 predicts patient prognosis and immunotherapy efficacy in clear cell renal cell carcinoma
por: Zhang, Zhentao, et al.
Publicado: (2023)